ICAP
ICAP at Columbia University is a non-profit global health organization founded in 2003 that delivers technical assistance, training, and survey research to ministries of health in nearly 50 countries, primarily on HIV/AIDS, tuberculosis, and health systems strengthening, funded largely by PEPFAR, USAID, and the Gates Foundation.
- Company typePrivate
- Founded2003
- HeadquartersNew York, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What ICAP does
ICAP at Columbia University is a non-profit global health organization founded in 2003 at Columbia University's Mailman School of Public Health by Dr. Wafaa El-Sadr, originally chartered as the International Center for AIDS Care and Treatment Programs. Headquartered in New York with field operations across nearly 50 countries and 1,001-5,000 staff, ICAP delivers technical assistance, capacity building, and survey/research services to ministries of health in low- and middle-income countries, with a historical focus on HIV/AIDS that has expanded to tuberculosis, malaria, COVID-19, maternal and child health, non-communicable diseases, antimicrobial resistance, migrant health, and pandemic preparedness. Core offerings include the Programmatic Support Award and Global Technical Assistance programs, the CQUIN and HIVE multi-country learning and impact networks, the Population-based HIV Impact Assessment (PHIA) survey franchise, health information systems support (DHIS2 implementation, Laboratory Information Management Systems), and an e-learning/training catalog delivered in multiple languages.
The organization's technology footprint centers on health information systems and survey methodology rather than commercial software products: DHIS2 national electronic health information system implementations, LIMS for laboratory data management, TRACE rapid recency testing for HIV surveillance, electronic ART registration systems, and the LeCellPHIA cell-phone-based surveillance platform. Survey offerings — PHIA, Violence Against Children and Youth Surveys (VACS), and Biobehavioral Surveys using respondent-driven sampling — produce nationally representative epidemiological data that feeds back into PEPFAR programming decisions.
ICAP's business model is grant-funded rather than commercial. Revenue streams flow from U.S. President's Emergency Plan for AIDS Relief (PEPFAR) cooperative agreements via CDC and USAID, foundation grants (notably the Bill & Melinda Gates Foundation for CQUIN and HIVE), university research funding, and additional support from organizations such as the Elton John AIDS Foundation. Services are delivered through direct technical assistance to government health systems, partnerships with national public health institutes, healthcare facility engagement, and community-based organizations, with field offices in 40+ countries supported by the New York headquarters and a Global Support Hub in South Africa. ICAP reports cumulative impact metrics including 51 million HIV tests, 9.2 million TB screenings, 2.4 million HIV treatments initiated, 12 million pregnant women tested, support to 2,100+ laboratories, and training of 194,000+ health workers.
ICAP firmographics
Firmographics- Name
- ICAP
- Legal name
- ICAP at Columbia University
- Website
- https://icap.columbia.edu
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- ICAP at Columbia University is a non-profit global health organization founded in 2003 that delivers technical assistance, training, and survey research to ministries of health in nearly 50 countries, primarily on HIV/AIDS, tuberculosis, and health systems strengthening, funded largely by PEPFAR, USAID, and the Gates Foundation.
- Ownership category
- akta.pro rank
ICAP industry classification
Industry- Product category
- Global Public Health Services
- NAICS
- Colleges, Universities, and Professional Schools (6113), Colleges, Universities, and Professional Schools (611310), Social Assistance (624), Educational Support Services (611710)
- SIC
- Services-Health Services (8000), Services-Educational Services (8200), Services-Misc Health & Allied Services, Nec (8090)
- akta.pro industry
- Communicable Disease Prevention & Control (HIV/AIDS, TB, Malaria, NTDs)Business & Public Services/International Organizations & Development/Global Health & Population ProgramsInternational & Global Public Health Aid Administration (Government Donors)Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Funding, Grants & Program AdministrationInfectious Disease & Immunization Program FundingHealthcare & Life Sciences/Public Health, Government & Regulators/Public Health Funding, Grants & Program AdministrationGlobal Health Institutes & ProgramsDisaster Response Coordination & Incident Command (EOC/ICS)Healthcare & Life Sciences/Public Health, Government & Regulators/Emergency Preparedness, Disaster Response & EMS Coordination
Keywords
Where ICAP is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
ICAP business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Revenue model
- Government Grants and PEPFAR Funding: Primary funding from U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC) and United States Agency for International Development (USAID)
- Foundation Grants: Funding from foundations including the Bill & Melinda Gates Foundation for initiatives like the CQUIN network and HIVE program for vertical transmission elimination
- University Research Funding: Research grants from various institutions and government agencies supporting implementation science, epidemiological, clinical, and behavioral research
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
ICAP product offering
Product offeringCore offering
ICAP at Columbia University is a non-profit global health organization that delivers technical assistance, capacity building, training, and survey/research services to ministries of health and healthcare facilities in low- and middle-income countries. Its core work focuses on scaling up HIV prevention, care, and treatment, while also addressing tuberculosis, malaria, maternal and child health, non-communicable diseases, antimicrobial resistance, and pandemic preparedness through multi-year programs funded by PEPFAR, CDC, USAID, and the Gates Foundation.
Product overview
ICAP at Columbia University is a global health organization that provides a comprehensive portfolio of public health services, technical assistance, training programs, and survey/research initiatives rather than a unified software product. The core offerings include: (1) Training and Education Programs - elearning courses (Pediatric HIV, Treat-All Approach via ColumbiaX), training packages (COVID-19 Clinical Management, Pediatric Multi-Month Dispensing), and the Nurse Mentorship Teaching Program; (2) Toolkits and Technical Resources - Pre-exposure Prophylaxis (PrEP) Package, technical guides, and standard operating procedures; (3) Survey Programs - Population-based HIV Impact Assessment (PHIA) Project, Violence Against Children and Youth Surveys (VACS), Biobehavioral Surveys (BBS), LeCellPHIA phone surveillance; (4) Learning Networks - CQUIN (HIV Coverage, Quality, and Impact Network) for differentiated service delivery, HIVE (HIV Impact Network for Vertical Transmission Elimination); (5) Health Information Systems Support - DHIS2 implementation, Laboratory Information Management Systems (LIMS), HIV Insight Dashboard, TRACE recency testing, electronic ART registration; (6) Global Technical Assistance - multi-country programs providing implementation support across HIV, TB, malaria, and health systems strengthening. These offerings work together to support ministries of health in strengthening health systems and improving population health outcomes.
Differentiator
Problem solved
Functional benefit
Brands
- HIVE (HIV Impact Network for Vertical Transmission Elimination): A Gates Foundation-funded initiative promoting peer learning, data-informed decision-making, and effective prevention and treatment approaches for vertical HIV transmission elimination across six African countries.
- CQUIN (HIV Coverage, Quality, and Impact Network)
- PHIA (Population-based HIV Impact Assessment)
- Next Generation Program
Products and services
- Global Technical Assistance Multi-year technical assistance providing implementation support, capacity building, and technical expertise across HIV technical domains including pediatric and adult HIV care, testing, prevention, health systems strengthening, human resources for health, strategic information, surveillance, and laboratory services for ministries of health.
- Programmatic Support Award (PSA) Five-year program designed to provide comprehensive and cost-effective technical support that accelerates evidence-based HIV prevention and treatment program implementation and strengthens health systems in PEPFAR-supported countries.
- Population-based HIV Impact Assessment (PHIA) Project Multi-country initiative of nationally representative, population-based HIV surveys that measure current status and effectiveness of national HIV programs. Each survey offers household-based HIV counseling and testing with immediate return of results.
- HIV Coverage, Quality, and Impact Network (CQUIN) Multi-country learning network dedicated to improving differentiated service delivery for people living with HIV, fostering joint learning and information exchange across participating countries.
- HIV Impact Network for Vertical Transmission Elimination (HIVE) Network promoting peer learning, data-informed decision-making, and effective prevention and treatment approaches for vertical HIV transmission elimination, supporting Kenya, Mozambique, Nigeria, South Africa, Tanzania, and Zambia.
- Laboratory Information Management Systems (LIMS) Implementation Implementation and rollout support for laboratory information management systems to improve turnaround time of test results and manage laboratory data across national laboratory networks.
- DHIS2 Implementation Support Technical support for adoption and implementation of District Health Information Software 2 (DHIS2) as national electronic health information systems in country health programs.
- Quality Management Systems (QMS) for Laboratories Technical assistance to countries on national planning and rollout of quality laboratory-based data management systems and scale-up of laboratory accreditation programs.
- Tracking with Recency Assays to Control the Epidemic (TRACE) Rapid recency testing program that uses a new rapid HIV test capable of distinguishing a recent HIV-1 infection (acquired within the last 12 months) to improve health interventions for people living with HIV.
- Violence Against Children and Youth Surveys (VACS) Nationally representative household surveys administered among adolescents and youth aged 13-24 years to provide data on lifetime and recent experiences of emotional, physical, and sexual violence.
- Biobehavioral Surveys (BBS) and Population Size Estimation Surveys providing population-level estimates of HIV burden and risk factors among key and vulnerable populations using respondent-driven sampling and other methods.
- LeCellPHIA Cell Phone Surveillance System Cell phone-based surveillance system involving weekly calling of consenting PHIA survey participants to survey influenza-like illness symptoms.
Quantifiable outcome
- 2.5 million people have accessed HIV care through ICAP support
- +6 more outcomes
Companies that use ICAP
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles3 records
ICAP technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
ICAP partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Columbia University Mailman School of Public HealthcoreICAP was founded at Columbia University's Mailman School of Public Health in 2003 under the leadership of Dr. Wafaa El-Sadr. The organization maintains its headquarters at Columbia University and benefits from the university's academic resources and research capabilities.
- Columbia University Climate SchoolminorCollaboration on the Solutions 4 Sustainability (S4S) project to evaluate the response of health systems in Mozambique to cyclones and climate change impacts on health.
- Paediatric-Adolescent Treatment Africa (PATA)corePartnership with PATA and Gates Foundation to launch the HIV Impact Network for Vertical Transmission Elimination (HIVE), aimed at eliminating vertical HIV transmission in six African countries with the highest burden of infant infection.
Scale indicators12 records
Recent moves27 records
Expansion highlights6 records
ICAP competitors and assessment
Company assessmentMarket position
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
ICAP social profiles
Digital presenceICAP financial estimates
Financial estimateRevenue estimate
Valuation estimate
ICAP leadership team
Management profileNumber of profiles
Profiles13 records
ICAP funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ICAP M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ICAP
What does ICAP do?
ICAP at Columbia University is a non-profit global health organization that delivers technical assistance, capacity building, training, and survey/research services to ministries of health and healthcare facilities in low- and middle-income countries. Its core work focuses on scaling up HIV prevention, care, and treatment, while also addressing tuberculosis, malaria, maternal and child health, non-communicable diseases, antimicrobial resistance, and pandemic preparedness through multi-year programs funded by PEPFAR, CDC, USAID, and the Gates Foundation.
Is ICAP a public or private company?
ICAP is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was ICAP founded?
ICAP was founded in 2003. It employs 501 to 1,000 people.
Where is ICAP based?
ICAP is headquartered in New York, United States, in the North America region.
How does ICAP make money?
Three revenue lines are on record. Government Grants and PEPFAR Funding is the primary driver. The others are foundation Grants and university Research Funding.
Does ICAP have an API?
No public API is recorded for ICAP.
What industry is ICAP in?
ICAP's product category is Global Public Health Services. Its primary akta.pro industry code is BPADAIAA, Communicable Disease Prevention & Control (HIV/AIDS, TB, Malaria, NTDs), with a secondary code of HLAJALAO, International & Global Public Health Aid Administration (Government Donors). Its NAICS code is 6113 and its SIC code is 8000.